Chong Lu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Natural Compounds in Disease Treatment
Papers in
-
- Circular RNAs in diseases 3
- DNA Repair Mechanisms 2
- Metabolism, Diabetes, and Cancer 2
-
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 3
- Co-authors
- Yongqing Lai (14 shared papers)Meng Zhang (6 shared papers)Guiling Li (5 shared papers)Jing Peng (5 shared papers)Yaping Zhou (2 shared papers)Pyone Myat Thu (3 shared papers)Xiaojun Xu (3 shared papers)Hui‐Jun Li (3 shared papers)
In The Last Decade
Chong Lu
44 papers receiving 407 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 91
- Complementary and alternative medicine 29
- Pharmacology 29
- Obstetrics and Gynecology 23
- Toxicology 9
Countries citing papers authored by Chong Lu
This map shows the geographic impact of Chong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong Lu more than expected).
Fields of papers citing papers by Chong Lu
This network shows the impact of papers produced by Chong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong Lu. The network helps show where Chong Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chong Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 48 | |
| 2 | 2017 | 41 | |
| 3 | 2016 | 32 | |
| 4 | 2010 | 28 | |
| 5 | 2020 | 20 | |
| 6 | 2020 | 19 | |
| 7 | 2023 | 18 | |
| 8 | 2021 | 16 | |
| 9 | 2022 | 13 | |
| 10 | 2024 | 13 | |
| 11 | 2023 | 12 | |
| 12 | 2022 | 11 | |
| 13 | 2024 | 11 | |
| 14 | 2023 | 10 | |
| 15 | 2010 | 10 | |
| 16 | 2021 | 9 | |
| 17 | 2022 | 8 | |
| 18 | 2024 | 8 | |
| 19 | 2018 | 8 | |
| 20 | 2023 | 7 |
About Chong Lu
Chong Lu is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Surgery, having authored 46 papers that have together received 415 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), Circular RNAs in diseases (3 papers), PARP inhibition in cancer therapy (3 papers), Cancer-related molecular mechanisms research (3 papers), DNA Repair Mechanisms (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Metabolism, Diabetes, and Cancer (2 papers) and Asthma and respiratory diseases (2 papers). The work is most often cited by research in Cancer Research (91 citations), Complementary and alternative medicine (29 citations), Pharmacology (29 citations), Obstetrics and Gynecology (23 citations) and Toxicology (9 citations). Chong Lu has collaborated with scholars based in China, Hong Kong and Australia. Frequent co-authors include Yongqing Lai, Meng Zhang, Guiling Li, Jing Peng, Yaping Zhou, Pyone Myat Thu, Xiaojun Xu, Hui‐Jun Li, Zu‐Guo Zheng and Zuhu Yu. Their work appears in journals such as International Journal of Molecular Sciences, Frontiers in Oncology, Frontiers in Genetics, European Journal of Pharmacology and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.